Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Large-scale testing (Phase 3)Study completedNCT02615691
What this trial is testing

PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 120
Early research (Phase 1)UnknownNCT00431808
What this trial is testing

Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])

Who this might be right for
Malaria
African Malaria Network Trust 40
Not applicableUnknownNCT05126550
What this trial is testing

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

Who this might be right for
COVID-19
PT. Kimia Farma (Persero) Tbk 435
Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Post-approval studies (Phase 4)UnknownNCT04053010
What this trial is testing

Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP

Who this might be right for
Vaccination
China National Biotec Group Company Limited 702
Testing effectiveness (Phase 2)Study completedNCT00426218
What this trial is testing

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Arthritis, Juvenile Rheumatoid
Novartis 26
Testing effectiveness (Phase 2)Study completedNCT00748813
What this trial is testing

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

Who this might be right for
Seasonal Influenza
Novartis Vaccines 133
Early research (Phase 1)Study completedNCT01302990
What this trial is testing

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

Who this might be right for
Flu
Medicago 100
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Early research (Phase 1)Study completedNCT00376090
What this trial is testing

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 48
Early research (Phase 1)Study completedNCT01829490
What this trial is testing

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Who this might be right for
Tuberculosis
University of Oxford 42
Testing effectiveness (Phase 2)Ended earlyNCT03531710
What this trial is testing

An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311

Who this might be right for
Alzheimer's Disease
United Neuroscience Ltd. 34
Early research (Phase 1)Study completedNCT06200597
What this trial is testing

A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Almirall, S.A. 92
Large-scale testing (Phase 3)Study completedNCT00761631
What this trial is testing

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

Who this might be right for
Healthy Subjects
Pfizer 1,200
Early research (Phase 1)Study completedNCT00001041
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT07095231
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00001445
What this trial is testing

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 32
Large-scale testing (Phase 3)WithdrawnNCT05166031
What this trial is testing

Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

Who this might be right for
Poliomyelitis
Fidec Corporation
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation